Andreas Brink
Impact in
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- DNA and Nucleic Acid Chemistry 6
- DNA Repair Mechanisms 4
- Advanced biosensing and bioanalysis techniques 4
- Metabolomics and Mass Spectrometry Studies 3
-
- Carcinogens and Genotoxicity Assessment 7
- Co-authors
- Werner K. Lutz (5 shared papers)Axel Pähler (5 shared papers)Simone Schadt (7 shared papers)Helga Stopper (5 shared papers)Ursula Lutz (2 shared papers)Ingrid Richter (2 shared papers)Christophe Husser (6 shared papers)Wolfgang Völkel (1 shared paper)
- Journals
- Mutation Research/Genetic Toxicology and Environmental Mutagenesis (3 papers)Investigational New Drugs (2 papers)Rapid Communications in Mass Spectrometry (2 papers)Toxicologic Pathology (2 papers)Toxicological Sciences (2 papers)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Andreas Brink
33 papers receiving 611 citations
Peers
Comparison fields: 5 of 89
- Nephrology 93
- Pharmacology 91
- Cancer Research 112
- Molecular Biology 309
- Spectroscopy 66
Countries citing papers authored by Andreas Brink
This map shows the geographic impact of Andreas Brink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Brink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Brink more than expected).
Fields of papers citing papers by Andreas Brink
This network shows the impact of papers produced by Andreas Brink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Brink. The network helps show where Andreas Brink may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Brink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 97 | |
| 2 | 2017 | 48 | |
| 3 | 2017 | 47 | |
| 4 | 2008 | 45 | |
| 5 | 2008 | 44 | |
| 6 | 2005 | 39 | |
| 7 | 2014 | 31 | |
| 8 | 2016 | 30 | |
| 9 | 2021 | 26 | |
| 10 | 2005 | 21 | |
| 11 | 2012 | 21 | |
| 12 | 2019 | 18 | |
| 13 | 2017 | 14 | |
| 14 | 2021 | 13 | |
| 15 | 2007 | 13 | |
| 16 | 2019 | 12 | |
| 17 | 2021 | 12 | |
| 18 | 2017 | 12 | |
| 19 | 2007 | 11 | |
| 20 | 2021 | 11 |
About Andreas Brink
Andreas Brink is a scholar working on Molecular Biology, Cancer Research, Oncology, Pharmacology and Organic Chemistry, having authored 33 papers that have together received 632 indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (7 papers), DNA and Nucleic Acid Chemistry (6 papers), Pharmacogenetics and Drug Metabolism (5 papers), DNA Repair Mechanisms (4 papers), Advanced biosensing and bioanalysis techniques (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Analytical Chemistry and Chromatography (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Nephrology (93 citations), Pharmacology (91 citations), Cancer Research (112 citations), Molecular Biology (309 citations) and Spectroscopy (66 citations). Andreas Brink has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Werner K. Lutz, Axel Pähler, Simone Schadt, Helga Stopper, Ursula Lutz, Ingrid Richter, Christophe Husser, Wolfgang Völkel, J. Schlatter and Marco Kellert. Their work appears in journals such as Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Investigational New Drugs, Rapid Communications in Mass Spectrometry, Toxicologic Pathology and Toxicological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.